tranexamic acid has been researched along with Nephrotic Syndrome in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wörn, M | 1 |
| Kalbacher, H | 1 |
| Artunc, F | 1 |
1 other study available for tranexamic acid and Nephrotic Syndrome
| Article | Year |
|---|---|
Proteolytic Activity against the Distal Polybasic Tract of the Gamma Subunit of the Epithelial Sodium Channel ENaC in Nephrotic Urine.
Topics: Amino Acids; Animals; Aprotinin; Epithelial Sodium Channels; Humans; Mice; Nephrotic Syndrome; Pepti | 2022 |